[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
October 23, 1954


JAMA. 1954;156(8):772-773. doi:10.1001/jama.1954.02950080020010

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


The purpose of antenatal antibody tests is to determine before delivery which Rh-negative expectant mothers have become sensitized, so that Rh-negative blood of a compatible A-B-O group can be made available to treat the baby promptly after birth, when necessary. In this way, lives of erythroblastotic babies can be saved and among affected babies who survive neurological sequelae can be prevented. Every Rh-negative multipara who has had a previous Rh-positive baby is a possible candidate for Rh sensitization, which may develop at any time during a pregnancy. If Rh sensitization does develop, it is probable that the baby will be erythroblastotic and may require treatment by exchange transfusion.

The first Rh antibody test should be done as soon as the patient becomes pregnant, to determine whether the patient is already sensitized at the beginning of the pregnancy and, if she is, what the level of the antibody titer is. Since

First Page Preview View Large
First page PDF preview
First page PDF preview